Skip to main content

Table 5 Comparison of patients with reduced and normal exercise capacity

From: Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for severe COVID-19

Variables

VO2 peak < 85% (n = 12)

VO2 peak ≥ 85% (n = 48)

p value

Patient’s characteristics

Age (years)

65.4 (59.8–72.3)

68.1 (58.1–71.8)

0.96

BMI (kg/m2)

33.4 ± 6.2

30.1 ± 4.5

0.04

Smoker or former smoker

8 (66.7%)

26 (54.2%)

0.52

ICU stay (days)

29.7 ± 13.1

19.1 ± 11.3

0.006

Ischemic heart disease

1 (8.3%)

4 (8.3%)

 > 0.99

COPD

1 (8.3%)

4 (8.3%)

 > 0.99

Asthma

2 (16.7%)

4 (8.3%)

0.59

Pulmonary embolism

3 (25%)

13 (27.1%)

0.88

Respiratory rehabilitation

9 (75%)

30 (62.5%)

0.41

Chest computed tomography scan #

Emphysema

4 (33.3%)

7 (14.6%)

0.69

Reticulations

9 (75%)

33 (68.7%)

 > 0.99

Traction bronchiectasis

8 (66.7%)

27 (56.2%)

0.74

Honeycombing

0 (0.0%)

3 (6.2%)

 > 0.99

Ground-glass opacities

4 (33.3%)

25 (52.1%)

0.24

Pulmonary function tests

FEV1 (% predicted)

97.4 ± 16.9

110.8 ± 19.7

0.03

FVC (% predicted)

97.5 ± 17.8

110.8 ± 16.9

0.01

TLC (%predicted)

87.7 ± 12.6

95.9 ± 14.3

0.07

DLCOcor (%predicted)

91.3 (65.6–98.1)

103 (92.3–114.2)

0.01

KCO (%predicted)

96.1 ± 29.9

104.8 ± 15.5

0.16

CPET at AT

   

PetCO2 (mmHg)

39.3 ± 6.9 *

39.6 ± 5.5 **

0.87

Anaerobic threshold (%VO2 peak predicted)

59.1 (49.1–65.2)

66.1 (58.1–73.2)

0.01

CPET at peak

Performance

Reasons for stopping exercise

 Leg discomfort

8 (66.7%)

25 (52.1%)

0.51

 Dyspnea discomfort

4 (33.3%)

18 (37.5%)

 > 0.99

 Both

0 (0.0%)

3 (6.2%)

 > 0.99

 Others

0 (0.0%)

2 (4.2%)

 > 0.99

Effort duration (sec)

547.6 ± 128.9

585.7 ± 86.2

0.21

Workload (% predicted)

85.7 (80.1–96.9)

107.2 (98.4–124.5)

 < 0.0001

V′O2 (L/min)

1.6 ± 0.5

2.0 ± 0.5

0.03

V′O2 (L/min, % predicted)

82.1 (73.7–83.7)

101.9 (94.6–107.7)

 < 0.0001

V′O2 (ml/min/kg)

16.9 ± 4.2

23.0 ± 4.7

0.0001

V′O2 (ml/min/kg, % predicted)

82 (73.9–83.9)

101.6 (94.8–107.5)

 < 0.0001

MET

4.8 ± 1.2

6.6 ± 1.3

0.0001

Ventilation

VE (L/min)

74.9 ± 21.9

83.6 ± 21.9

0.22

RER

1.1 ± 0.1

1.1 ± 0.1

0.14

Breathing reserve (%)

34.4 ± 15.4

32.1 ± 13.4

0.61

PetCO2 (mmHg)

34.0 ± 5.3 *

34.3 ± 5.3 **

0.86

Circulation

HR (beats/min, %predicted)

94.3 ± 11.9

97.2 ± 12.9

0.49

Heart rate reserve (%)

4.1 (0–18.6)

1.6 (0–14.7)

0.68

VO2 pulse (%predicted)

83.9 ± 11.3

108.7 ± 18.6

 < 0.0001

ΔHR/ΔV′O2

47.5 (36.6–51.2)

39.9 (32.2–47.5)

0.08

ΔV′O2/ΔWR

13.9 (12.9–16.1)

14.3 (13.6–15.3)

0.54

Gas exchange

VE/VO2 ratio

45.7 ± 7.9

42.1 ± 6.1

0.08

OUES (L/min)

1.6 (1.5–2.0)

1.9 (1.7–2.3)

0.14

VE/VCO2 ratio

39.5 (33.5–47.0)

37.5 (34–41)

0.36

VE/VCO2 slope

37.2 ± 7.6*

37.2 ± 6.6*

0.99

VD/Vt

0.35 (0.28–0.40)*

0.29 (0.25–0.34)**

0.06

pH

7.3 ± 0.04**

7.3 ± 0.05

0.36

pCapO2 (mmHg)

78.2 (54.2–82.1)*

83.8 (76.8–87.1)**

0.05

pCapCO2 (mmHg)

35.9 (33.4–39.4)**

34.7 (30.7–37.3)

0.14

P(A-a) (mmHg)

43.49 (29.7–60.5)*

35.2 (31.2–44.8)**

0.23

Metabolic

Lactatemia (mmol/L)

7.2 ± 2.4*

7.7 ± 2.2

0.54

  1. Data are shown as the number of subjects (%), means ± SD or medians [first quartile; third quartile], Student’s t- or Mann–Whitney tests were computed to assess statistical differences for normal or non-normal quantitative. Fisher’s exact test was used for analysis of contingency tables
  2. BMI, Body mass index; ICU, Intensive care unit; COPD: Chronic obstructive pulmonary disease; FEV1, Forced expiratory volume at 1st second; FVC, Forced vital capacity; TLC, Total lung capacity; DLCOcor, Lung transfer for carbon monoxide; KCO, Carbon monoxide transfer coefficient; V′O2, Oxygen uptake; MET, Metabolic equivalent; RR, Respiratory rate; V′E, Minute ventilation; RER, Respiratory exchange ratio; PetCO2, End-tidal pressure of CO2; HR, Heart rate; WR: Work rate; V′CO2, Carbon dioxide production; OUES, Oxygen uptake efficiency slope; V′E/V′O2 and V′E/V′CO2, Ventilatory equivalents for oxygen and carbon dioxide; VD, Dead space; Vt, Tidal volume; PcapO2, Capillary arterialized pO2; PcapCO2, Capillary arterialized pCO2; P(A-a)O2; Alveolar-arterial gradient for O2
  3. *Missing values for n = 2 patients
  4. **Missing values for n = 1 patient
  5. Bold represents p-values that are statistically significant